Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Maurits den Boer, Ph.D.
Co-Founder and CEO at Abvion
Speaker

Profile

Maurits den Boer is co-founder and CEO of Abvion, an Utrecht University spin-off advancing serological antibody discovery by proteomics. With a background in biotechnology, he earned a PhD on "Exploring Humoral Immune Responses by Mass Spectrometry”. His research focused on characterizing antibody structures, interactions, and repertoires using native and top-down mass spectrometry, enabling innovative approaches for therapeutic antibody development.

Agenda Sessions

  • Direct Serological Antibody Discovery by Integrative Proteomics Yields Potent Neutralizers Overlooked by Single-cell BCR Sequencing

    , 15:25
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Maurits at Antibody Engineering & Therapeutics Europe